21 Jun 2016
The FEI has announced an adverse analytical finding involving prohibited substances.
Samples taken at the 80km CEI*1 in Amman (JOR) on 21 May 2016 from the second-placed horse Obama Al Aswad (FEI ID 104DF50, ridden by Nayef Al Fayez (FEI ID 10066952), have returned positive for the banned substance Boldenone, and the controlled medications Dexamethasone, Meloxicam, Phenylbutazone and its metabolite Oxyphenbutazone.
Boldenone, an anabolic steroid, is a banned substance under the FEI’s Equine Anti-Doping and Controlled Medication Regulations (EADCMRs).
The corticosteroid Dexamethasone is used to treat inflammatory and auto-immune conditions, while the non-steroidal anti-inflammatory drugs Meloxicam, Phenylbutazone and its metabolite Oxyphenbutazone are used for pain relief.
The athlete has been provisionally suspended from the date of notification (20 June 2016). The horse has also been provisionally suspended for a two-month period.
Further details on this case can be found here.
Horsetalk.co.nz - Full Article April 12, 2021 Horsetalk.co.nz The organisers of next month’s Longines FEI Endurance World Championsh...
November 4 2013 "Our current FEI [endurance] rules are founded on ethical compromise, bias, and the warped sense of reality of powerf...
Jewishexponent.com - full article By Sophie Panzer -December 17, 2020 No adventure was too daunting for Rose Sandler. The Pipersville nat...
ElRaidBlog - Full Article January 12, 2021 Gabriel Gamiz [google translate] Today I get the sad news of the death of a great horse «NO...